Gan & Lee Pharmaceuticals.

This study tests whether a new once-weekly insulin (GZR4) works as well as a daily insulin (glargine) in people with type 2 diabetes who already use insulin. About 580 adults will take part, and researchers will measure blood sugar control, side effects, and weight changes. The g…

This study tests a new injectable medicine called GZR18 in Chinese adults with type 2 diabetes whose blood sugar is not well controlled by diet and exercise alone. The goal is to see if the drug safely lowers blood sugar and helps with weight loss. About 274 participants will rec…

This early-stage study tests a single dose of the experimental drug GZR4 in 36 adults with diabetes who also have mild, moderate, or severe liver impairment. The goal is to see how the drug moves through the body and whether it is safe in these patients. This study does not aim t…